All News

Strategy

Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
14 May 2024
Intensified extracellular vesicle production in fixed-bed bioreactors: Discover low-footprint, automated solutions for low-cost extracellular vesicles manufacturing
Are you looking for a
Learning From Experience: Navigating Cell & Gene Therapy Development Challenges with Productive CDMO Partnerships
9 May 2024
Learning From Experience: Navigating Cell & Gene Therapy Development Challenges with Productive CDMO Partnerships
In this interview, Andy Lewin,
Smoothing the Road to Cell and Gene Therapy Commercialization
27 March 2024
Smoothing the Road to Cell and Gene Therapy Commercialization
In interview, filmed on the
Maximizing cost efficiency, reducing GMP footprint, and eliminating bottlenecks in Lentiviral virus production: A Case Study with the Cytegrity™ Producer Cell Line in the scale-X™ Fixed-Bed Bioreactor.
25 March 2024
Maximizing cost efficiency, reducing GMP footprint, and eliminating bottlenecks in Lentiviral virus production: A Case Study with the Cytegrity™ Producer Cell Line in the scale-X™ Fixed-Bed Bioreactor.
Discover revolutionary advancements in LVV
POPULAR NEWS ITEMS
Image
26 November 2024

ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies

Image
19 November 2024

Texas Cell and Gene Manufacturing Landscape

Image
12 November 2024

Full Agenda Released for Advanced Therapies Week 2025 in Dallas

Bridging the Gap: How Innovation-Driven Partnerships Fuel the Pace of Cell Therapy Manufacturing Development
12 March 2024
Bridging the Gap: How Innovation-Driven Partnerships Fuel the Pace of Cell Therapy Manufacturing Development
Michelle Duquette, Chief Scientist -
Employing Innovative Approaches, Technological Advancements and Collaborative Strategies to Address Industry Challenges
29 February 2024
Employing Innovative Approaches, Technological Advancements and Collaborative Strategies to Address Industry Challenges
Sharmilee Patel, Head of Business
Decentralized Manufacturing: Delivering on the Promise of Cell and Gene Therapy
27 February 2024
Decentralized Manufacturing: Delivering on the Promise of Cell and Gene Therapy
Manufacturing capacity, complexity and cost
Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors
26 February 2024
Going Non-Viral: How Cell Therapy Manufacturing is Moving Away From Viral Vectors
Are you interested in editing
Load more News
RECOMENDED TOPICS
Clinical Trials
Collaborations, Mergers & Acquisitions
Finance & Investment
Patient Access & Engagement
Regulatory & Standards
Reimbursement
Strategy
POPULAR NEWS ITEMS
Image

ATW Speaker Patrick M Gailliot Previews Event and Discusses His Role in Autologous Cell and Gene Therapies

Image

Texas Cell and Gene Manufacturing Landscape

Image

Full Agenda Released for Advanced Therapies Week 2025 in Dallas